- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Remdesivir
Hyderabad: 8 held for illegally selling COVID-19 drugs
Hyderabad: 8 held for illegally selling COVID-19 drugs
Read MoreCOVID-19: Indiscriminate use of Remdesivir and Tocilizumab can cause more harm than good, says Health Ministry
COVID-19: Indiscriminate use of Remdesivir and Tocilizumab can cause more harm than good, says Health Ministry
Read MoreNo shortage of COVID-19 medicine in Goa, every patient treated as VIP: Rane
No shortage of COVID-19 medicine in Goa, every patient treated as VIP: Rane
Read MoreStrict action will be taken against black marketeers of Remdesivir: Anil Deshmukh
Strict action will be taken against black marketeers of Remdesivir: Anil Deshmukh
Read MoreGilead Says Remdesivir Reduced Risk Of Death In COVID-19 Patients, More Studies Needed
Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as in the study.
Read MoreGilead To Deliver More Remdesivir To Germany, Europe From The Fall
Remdesivir is currently the only drug granted a conditional marketing authorisation by the EU for its use in COVID-19 patients.
Read MoreCipla Prices Its Generic Remdesivir At $53.34 Per Vial, Below Rivals
Privately held Hetero Labs Ltd's version, Covifor, costs 5,400 rupees per vial while Mylan prices Desrem at 4,800 rupees.
Read MoreCOVID19: Top drug regulator directs states drug controller to be vigilant to stop black marketing of anti-drug Remdesivir
COVID19: Top drug regulator directs states drug controller to be vigilant to stop black marketing of anti-drug Remdesivir
Read MoreMylan Gets DCGI Nod For Remdesivir In India, To Launch At Rs 4,800 Per Vial
The drug will be launched under the brand name Desrem in India and will be available to patients later this month at about 80 per cent below the price tag for wealthy nations.
Read MoreHealth ministry revises remdesivir dosage for COVID-19 patients
Health ministry revises remdesivir dosage for COVID-19 patients
Read MoreDCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients
DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients
Read MoreSouth Korea Says To Begin Talks To Purchase COVID-19 Drug Remdesivir In August
South Korea has reported a total of 12,850 coronavirus cases as of Tuesday with 282 deaths.
Read MoreGilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nations
Cipla's version is priced at less than 5,000 Indian rupees ($66.24), while Hetero Lab's version is priced at 5,400 rupees ($71.54).
Read MoreCOVID-19: States being delivered generic version of Remdesivir, 20 thousand vials ready costing Rs 5400 per injection, says Hetero
COVID-19: States being delivered generic version of Remdesivir, 20 thousand vials ready costing Rs 5400 per injection, says Hetero
Read MoreIndia's Hetero Prices Experimental COVID-19 Drug Remdesivir At $71 Per 100 mg Vial
Fellow Indian drug firm Cipla Ltd had said on Tuesday that its own version of the antiviral drug remdesivir would be priced below Rs 5,000
Read More